Banc of America upgraded Sybron Dental Specialties (SYD) to buy from neutral, explaining that the company's operating savings initiatives and dental implant business will be more accretive than expected.
Analyst Frank Pinkerton says the company's dental implant business will generate about $35 million in 2006 sales. He thinks the market growth will change this business from an earnings per share (EPS) drain in fiscal year 2006 (ending Sept.) to EPS contributor in fiscal year 2008, as it leverages its new salesforce. Also, he remains positive on the broader dental market and the company's positioning in it. He raises his $43 stock price target to $48.